STOCK TITAN

Insider for Company (NASDAQ: PBYI) files Rule 144 to sell 5,014 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Douglas Hunt filed a notice under Rule 144 to sell 5,014 shares of common stock through Fidelity Brokerage Services LLC on or about 01/07/2026 on the NASDAQ market. These 5,014 shares were acquired on 01/02/2026 via restricted stock vesting from the issuer as compensation. The filing notes that 50,391,107 shares of the issuer’s common stock were outstanding. During the prior three months, Hunt sold 3,973 common shares on 01/06/2026 for gross proceeds of 24,216.62.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for PBYI disclose?

The Form 144 notice discloses an intended sale of 5,014 shares of common stock on or about 01/07/2026 under Rule 144.

How many PBYI shares are planned to be sold under this Rule 144 notice?

The filer plans to sell 5,014 shares of common stock, as stated in the securities information section.

How and where will the PBYI shares be sold?

The planned sale of 5,014 common shares is through Fidelity Brokerage Services LLC and is listed for trading on the NASDAQ exchange.

When were the PBYI shares to be sold under Form 144 acquired?

The 5,014 common shares were acquired on 01/02/2026 via restricted stock vesting from the issuer as compensation.

How many PBYI shares are outstanding according to this notice?

The filing cites 50,391,107 shares of common stock outstanding for the issuer.

Have there been recent PBYI share sales by this filer?

Yes. The notice lists a sale on 01/06/2026 of 3,973 common shares, with gross proceeds of 24,216.62.

What does the Form 144 filer represent about non-public PBYI information?

By signing the notice, the filer represents that they do not know any material adverse information about the issuer’s operations that has not been publicly disclosed.

Puma Biotechnology Inc

NASDAQ:PBYI

PBYI Rankings

PBYI Latest News

PBYI Latest SEC Filings

PBYI Stock Data

321.50M
42.77M
15.43%
68.25%
5.49%
Biotechnology
Pharmaceutical Preparations
Link
United States
LOS ANGELES